Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 193
. Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release of Celldex Therapeutics, Inc., dated February 25, 2026. 104 Cover Page Interactive Data Fil